Detailed Information on Publication Record
2023
Anti-Cancer Properties of Resveratrol: A Focus on Its Impact on Mitochondrial Functions
KURSVIETIENE, Lolita, Dalia M KOPUSTINSKIENE, Inga STANEVICIENE, Ausra MONGIRDIENE, Kateřina KUBOVÁ et. al.Basic information
Original name
Anti-Cancer Properties of Resveratrol: A Focus on Its Impact on Mitochondrial Functions
Authors
KURSVIETIENE, Lolita, Dalia M KOPUSTINSKIENE, Inga STANEVICIENE, Ausra MONGIRDIENE, Kateřina KUBOVÁ (203 Czech Republic, belonging to the institution), Ruta MASTEIKOVÁ (203 Czech Republic, belonging to the institution) and Jurga BERNATONIENE (guarantor)
Edition
Antioxidants, Basel, MDPI, 2023, 2076-3921
Other information
Language
English
Type of outcome
Článek v odborném periodiku
Field of Study
30104 Pharmacology and pharmacy
Country of publisher
Switzerland
Confidentiality degree
není předmětem státního či obchodního tajemství
References:
Impact factor
Impact factor: 7.000 in 2022
RIV identification code
RIV/00216224:14160/23:00133208
Organization unit
Faculty of Pharmacy
UT WoS
001136105900001
Keywords in English
resveratrol; cancer; mitochondria
Tags
International impact, Reviewed
Změněno: 5/4/2024 07:46, Mgr. Daniela Černá
Abstract
V originále
Cancer is one of the most serious public health issues worldwide, demanding ongoing efforts to find novel therapeutic agents and approaches. Amid growing interest in the oncological applications of phytochemicals, particularly polyphenols, resveratrol-a naturally occurring polyphenolic stilbene derivative-has emerged as a candidate of interest. This review analyzes the pleiotropic anti-cancer effects of resveratrol, including its modulation of apoptotic pathways, cell cycle regulation, inflammation, angiogenesis, and metastasis, its interaction with cancer stem cells and the tumor microenvironment. The effects of resveratrol on mitochondrial functions, which are crucial to cancer development, are also discussed. Future research directions are identified, including the elucidation of specific molecular targets, to facilitate the clinical translation of resveratrol in cancer prevention and therapy.